Form 4: Boston Scientific Director Jessica L. Mega Reports Stock Award and Disposal

Director Jessica L. Mega reported the acquisition of 2,901 shares of Boston Scientific common stock as an annual equity award and the disposal of 6,154 shares.

Summary

• On May 9, 2024, Jessica L. Mega, a director of Boston Scientific Corp, reported a transaction involving the company's common stock.
• Mega acquired 2,901 shares as an annual equity award, valued at $0.00 per share.
• These shares vest fully upon the next annual meeting of stockholders.
• Mega also disposed of 6,154 shares.
• Following these transactions, Mega directly owns 6,154 shares of Boston Scientific common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports stock transactions by a company director, which is a routine occurrence.

Positives

• The acquisition of shares as an equity award aligns the director's interests with those of the shareholders.

Negatives

• The disposal of 6,154 shares could be interpreted negatively by some investors, although the reason for disposal is not specified.

Risks

• The document does not explicitly mention any risks.
• However, any disposal of shares by a director could be perceived as a lack of confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The transactions may have a minor impact on shareholder sentiment, depending on how the disposal of shares is perceived.

Next Steps

• The acquired shares will vest upon the next annual meeting of stockholders.

Key Dates